The results showed that the PD-L1 expression of the tumor cells was 20–30% (Fig. 2), TMB was 58.58 mutations/Mb, and intriguingly, a novel NCOR2-NTRK1 fusion was detected (Table 1, Fig. 3). The gene discussed is NTRK1; the disease is neoplasm.